| Identification | Back Directory | [Name]
1-cyclobutyl-4-[1-(5,6,7,8-tetrahydronaphthalene-2
-sulfonyl)-4,5-dihydro-1H-imidazol-2-yl]piperazine | [CAS]
1965248-33-2 | [Synonyms]
KDM2B-IN-1
1-cyclobutyl-4-[1-(5,6,7,8-tetrahydronaphthalene-2
-sulfonyl)-4,5-dihydro-1H-imidazol-2-yl]piperazine
Piperazine, 1-cyclobutyl-4-[4,5-dihydro-1-[(5,6,7,8-tetrahydro-2-naphthalenyl)sulfonyl]-1H-imidazol-2-yl]- | [Molecular Formula]
C21H30N4O2S | [MOL File]
1965248-33-2.mol | [Molecular Weight]
402.55 |
| Chemical Properties | Back Directory | [Boiling point ]
556.6±60.0 °C(Predicted) | [density ]
1.41±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
7.89±0.70(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
KDM2B-IN-1 is a histone demethylase (kdm2b) inhibitor and can be used for hyperproliferative diseases research[1]. | [References]
[1] Brian K. Albrecht, et al. 4,5-dihydroimidazole derivatives and their use as histone demethylase (kdm2b) inhibitors. Patent WO2016112251A1. |
|
|